vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $334.0M, roughly 1.2× WYNDHAM HOTELS & RESORTS, INC.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -18.0%, a 23.2% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
GRDN vs WH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $334.0M |
| Net Profit | $20.9M | $-60.0M |
| Gross Margin | 21.5% | — |
| Operating Margin | 7.7% | — |
| Net Margin | 5.3% | -18.0% |
| Revenue YoY | — | -76.3% |
| Net Profit YoY | — | -170.6% |
| EPS (diluted) | — | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | $397.6M | $334.0M | ||
| Q3 25 | $377.4M | $382.0M | ||
| Q2 25 | $344.3M | $397.0M | ||
| Q1 25 | $329.3M | $316.0M | ||
| Q4 24 | — | $336.0M | ||
| Q3 24 | $314.4M | $396.0M | ||
| Q2 24 | — | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | $20.9M | $-60.0M | ||
| Q3 25 | $9.8M | $105.0M | ||
| Q2 25 | $9.0M | $87.0M | ||
| Q1 25 | $9.4M | $61.0M | ||
| Q4 24 | — | $85.0M | ||
| Q3 24 | $-122.0M | $102.0M | ||
| Q2 24 | — | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | -11.4% | ||
| Q3 25 | 4.3% | 46.6% | ||
| Q2 25 | 3.7% | 37.8% | ||
| Q1 25 | 3.9% | 35.4% | ||
| Q4 24 | — | 38.4% | ||
| Q3 24 | -33.3% | 43.2% | ||
| Q2 24 | — | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | 5.3% | -18.0% | ||
| Q3 25 | 2.6% | 27.5% | ||
| Q2 25 | 2.6% | 21.9% | ||
| Q1 25 | 2.9% | 19.3% | ||
| Q4 24 | — | 25.3% | ||
| Q3 24 | -38.8% | 25.8% | ||
| Q2 24 | — | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | — | $-0.77 | ||
| Q3 25 | — | $1.36 | ||
| Q2 25 | — | $1.13 | ||
| Q1 25 | — | $0.78 | ||
| Q4 24 | — | $1.06 | ||
| Q3 24 | — | $1.29 | ||
| Q2 24 | — | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $64.0M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $217.9M | $468.0M |
| Total Assets | $412.7M | $4.2B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | $65.6M | $64.0M | ||
| Q3 25 | $36.5M | $70.0M | ||
| Q2 25 | $18.8M | $50.0M | ||
| Q1 25 | $14.0M | $48.0M | ||
| Q4 24 | — | $103.0M | ||
| Q3 24 | $37.2M | $72.0M | ||
| Q2 24 | — | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $34.3M | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | $217.9M | $468.0M | ||
| Q3 25 | $195.5M | $583.0M | ||
| Q2 25 | $179.7M | $570.0M | ||
| Q1 25 | $163.2M | $579.0M | ||
| Q4 24 | — | $650.0M | ||
| Q3 24 | $133.9M | $583.0M | ||
| Q2 24 | — | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $412.7M | $4.2B | ||
| Q3 25 | $390.0M | $4.3B | ||
| Q2 25 | $356.3M | $4.3B | ||
| Q1 25 | $334.0M | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | $348.0M | $4.2B | ||
| Q2 24 | — | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | 5.37× | ||
| Q3 25 | — | 4.43× | ||
| Q2 25 | — | 4.44× | ||
| Q1 25 | — | 4.29× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | 0.26× | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $367.0M |
| Free Cash FlowOCF − Capex | — | $168.0M |
| FCF MarginFCF / Revenue | — | 50.3% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | $34.6M | $152.0M | ||
| Q3 25 | $28.2M | $86.0M | ||
| Q2 25 | $19.9M | $70.0M | ||
| Q1 25 | $17.6M | $59.0M | ||
| Q4 24 | — | $134.0M | ||
| Q3 24 | — | $79.0M | ||
| Q2 24 | — | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | — | $136.0M | ||
| Q3 25 | $24.2M | $75.0M | ||
| Q2 25 | — | $58.0M | ||
| Q1 25 | — | $52.0M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | — | $71.0M | ||
| Q2 24 | — | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | — | 40.7% | ||
| Q3 25 | 6.4% | 19.6% | ||
| Q2 25 | — | 14.6% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | — | 17.9% | ||
| Q2 24 | — | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.8% | ||
| Q3 25 | 1.1% | 2.9% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.87× | 0.82× | ||
| Q2 25 | 2.21× | 0.80× | ||
| Q1 25 | 1.86× | 0.97× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
